National Blood Donor Month Spotlight: Heme Foundation's Future Contribution to Bridging the Gap in Blood Supply

National Blood Donor Month Spotlight: Heme Foundation's Future Contribution to Bridging the Gap in Blood Supply

Accesswire

Published

*In recognition of National Blood Donation Month, Pennsylvania-based nonprofit, Heme Foundation, launches an effort to develop an innovative solution to the global blood shortage.*

*BETHLEHEM, PA / ACCESSWIRE / January 3, 2024 /* This January, as the world observes National Blood Donor Month, the Heme Foundation plans to develop a product that will work towards the global effort to alleviate critical blood supply challenges. Despite international cooperation, many countries grapple with obstacles such as specialized handling, limited shelf life, and constant testing requirements for donated blood. Heme Foundation, however, is making significant strides to bridge this gap and create a healthier, safer, and more equitable world.

In a world where the demand for donated blood is ever-present, Heme Foundation recognizes the urgency of the challenges faced by countries worldwide. With the maximum "shelf life" of donated blood limited to 42 days and the demand for specialized handling and testing, there is a crucial need for innovative solutions to ensure a stable and reliable blood supply.

At the heart of Heme Foundation's contributions will be innovative technologies that offer alternatives to traditional blood donations. These solutions, to be developed for the foundation, will aim to provide a safe and effective means to address the challenges associated with the handling and availability of donated blood. By developing groundbreaking technologies, Heme Foundation will be paving the way for a more sustainable and accessible blood supply system.

The Heme Foundation has partnered with the inventors of a revolutionary therapy, universal oxygen carrier (UOC) which can be used in place of red blood cell transfusions. UOC has been proven in clinical tests to be a safe and effective replacement therapy. This life-saving solution can be used when traditional blood supplies are not available.

"Once UOC is approved, the Heme Foundation would control its manufacturing and distribution, which is a unique role for a nonprofit," says Heme Foundation's Jonathan Barkman.

The Heme Foundation has set a fundraising goal of raising at least $10-million to begin the approval process for UOC, which will take approximately 3 years.

"UOC is a game-changer and will save many lives, which is why we're so excited to share the opportunity with like-minded donors and foundations," Barkman says.

For more information on the Heme Foundation, visit their website hemefoundation.org.

*Contact Information:*
Name: Jonathan Barkman
Company: Heme Foundation
Address: Bethlehem, PA
Email: jbarkman@hemefoundation.org
Phone: 484-484-3025
Website: https://hemefoundation.org

*SOURCE:* Heme Foundation
View the original press release on accesswire.com

Full Article